| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | NSC 74859 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |